Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

3,800.00p
   
  • Change Today:
    -10.00p
  • 52 Week High: 4,100.00
  • 52 Week Low: 2,750.00
  • Currency: UK Pounds
  • Shares Issued: 5.14m
  • Volume: 1,010
  • Market Cap: £195.42m
  • Beta: 0.00

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Peter John Harrison 428,176 £16,270,688
Ian James Nicholson 18,000 £684,000

Major Shareholders

Notifier** Holding Value*
Castlefield Fund Partners Limited 985,000 £37,430,000
Miton Group plc 508,135 £19,309,130
Liontrust Investment Partners LLP 395,035 £15,011,330
Gresham House Asset Management Limited 355,675 £13,515,650
Canaccord Genuity Group Inc 328,500 £12,483,000
The Diverse Income Trust plc 302,300 £11,487,400
Wasatch Advisors, Inc. 265,000 £10,070,000
Adrian Williams 253,372 £9,628,136

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Bioventix Market Data

Currency UK Pounds
Share Price 3,800.00p
Change Today -10.00p
% Change -0.26 %
52 Week High 4,100.00
52 Week Low 2,750.00
Volume 1,010
Shares Issued 5.14m
Market Cap £195.42m
Beta 0.00

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
83.59% below the market average83.59% below the market average83.59% below the market average83.59% below the market average83.59% below the market average
93.1% below the sector average93.1% below the sector average93.1% below the sector average93.1% below the sector average93.1% below the sector average
Price Trend
77.90% above the market average77.90% above the market average77.90% above the market average77.90% above the market average77.90% above the market average
55.93% above the sector average55.93% above the sector average55.93% above the sector average55.93% above the sector average55.93% above the sector average
Income
30.53% below the market average30.53% below the market average30.53% below the market average30.53% below the market average30.53% below the market average
40% below the sector average40% below the sector average40% below the sector average40% below the sector average40% below the sector average
Growth
45.57% above the market average45.57% above the market average45.57% above the market average45.57% above the market average45.57% above the market average
72.97% above the sector average72.97% above the sector average72.97% above the sector average72.97% above the sector average72.97% above the sector average

Bioventix Dividends

  Latest Previous
  Interim Final
Ex-Div 11-Apr-19 25-Oct-18
Paid 26-Apr-19 09-Nov-18
Amount 30.00p 36.00p

Trades for 20-Sep-2019

Time Volume / Share Price
14:04 3 @ 3,800.00p
11:43 500 @ 3,750.00p
08:43 507 @ 3,770.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
Finance Director Treena Joan Turner

Top of Page